Recent advances in messenger ribonucleic acid (mRNA) vaccines and their delivery systems: a review
Messenger ribonucleic acid (mRNA) was found as the intermediary that transfers genetic
information from DNA to ribosomes for protein synthesis in 1961. The emergency use …
information from DNA to ribosomes for protein synthesis in 1961. The emergency use …
Adjuvant system AS01: from mode of action to effective vaccines
F Roman, W Burny, MA Ceregido… - Expert Review of …, 2024 - Taylor & Francis
Introduction The use of novel adjuvants in human vaccines continues to expand as their
contribution to preventing disease in challenging populations and caused by complex …
contribution to preventing disease in challenging populations and caused by complex …
A review on RNA interference studies in Anophelines to reveal candidate genes for malaria transmission blocking vaccine
M Yadav, N Dahiya, S Janjoter, D Kataria, R Dixit… - Life Sciences, 2024 - Elsevier
Malaria is a major public health concern. The development of parasite-based vaccine
RTS/AS01 has some therapeutic value but its lower efficacy is one of the major limitations …
RTS/AS01 has some therapeutic value but its lower efficacy is one of the major limitations …
Recent advances on vaccines against malaria: A review
S Malik, Y Waheed - Asian Pacific Journal of Tropical Medicine, 2024 - journals.lww.com
This review aims to summarize the currently viable vaccine strategies including the
approved vaccines and the those in trials for next-generation malaria vaccines. Data on …
approved vaccines and the those in trials for next-generation malaria vaccines. Data on …
[PDF][PDF] Current Developments in Malaria Vaccination: A Concise Review on Implementation, Challenges, and Future Directions
M Sallam, AO Al-Khatib, K Al-Mahzoum, DH Abdelaziz… - 2024 - researchgate.net
Malaria remains a persistent challenge in global health, disproportionately affecting
populations in endemic regions (eg, sub-Saharan Africa). Despite decades of international …
populations in endemic regions (eg, sub-Saharan Africa). Despite decades of international …
Frequency of serious adverse events and death in 5-17 months children receiving RTS, S/AS01E vaccine-a systematic review and meta-analysis of RCTs.
AZ Bindzi, RN Linjouom, MN Ndongo, JR Nkeck, L Yan… - 2024 - researchsquare.com
Background The RTS, S/AS01E vaccine has been authorized for use in children in sub-
Saharan Africa from the age of 5 months. Nevertheless, there is a limited number of clinical …
Saharan Africa from the age of 5 months. Nevertheless, there is a limited number of clinical …